AERIUS Now Approved For Use In Intermittent And Persistent Allergic Rhinitis
Schering-Plough Corporation today announced the launch of two multinational clinical trials, and an important label change for AERIUS (desloratadine) in the European Union (EU). [click link for full article]
(more...)
(more...)